Study on the Single Dose Toxicity of ShinEumHur Pharmacopuncture Injected into the Muscles of Rats
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: This study was carried out to analyze the single dose toxicity of ShinEumHur (SEH) pharmacopuncture injected into the muscles of Sprague-Dawley rats. Methods: The SEH pharmacopuncture was made in a clean room at the Korean Pharmacopuncture Institute (K-GMP). After the mixing process with sterile distilled water had been completed, the pH was controlled to between 7.0 and 7.5. All experiments were conducted at Biotoxtech, an institution authorized to perform non-clinical studies under the Good Laboratory Practice (GLP) regulations. Sprague-Dawley rats were chosen for the pilot study. Doses of SEH pharmacopuncture, 0.25, 0.5 and 1.0 mL, were administered to the experimental groups, and a dose of normal saline solution, 1.0 mL, was administered to the control group. We examined the survival rate, weights, clinical signs, mean hematology parameters, mean clinical chemistry, necropsy and histopathological findings. This study was conducted under the approval of the Institutional Animal Ethics Committee. Results: No deaths or abnormalities occurred in any of the four groups. No significant changes in weight, hematological parameters or clinical chemistry between the control group and the experimental groups were observed. To check for abnormalities in organs and tissues, we used microscopy to examine representative histological sections of each specified organ; the results showed no significant differences in any of the organs or tissues. Conclusion: The above findings suggest that treatment with SEH pharmacopuncture is relatively safe. Further studies on this subject are needed to yield more concrete evidence.
Abstract
Objectives: This study was carried out to analyze the single dose toxicity of ShinEumHur (SEH) pharmacopuncture injected into the muscles of Sprague-Dawley rats. Methods: The SEH pharmacopuncture was made in a clean room at the Korean Pharmacopuncture Institute (K-GMP). After the mixing process with sterile distilled water had been completed, the pH was controlled to between 7.0 and 7.5. All experiments were conducted at Biotoxtech, an institution authorized to perform non-clinical studies under the Good Laboratory Practice (GLP) regulations. Sprague-Dawley rats were chosen for the pilot study. Doses of SEH pharmacopuncture, 0.25, 0.5 and 1.0 mL, were administered to the experimental groups, and a dose of normal saline solution, 1.0 mL, was administered to the control group. We examined the survival rate, weights, clinical signs, mean hematology parameters, mean clinical chemistry, necropsy and histopathological findings. This study was conducted under the approval of the Institutional Animal Ethics Committee. Results: No deaths or abnormalities occurred in any of the four groups. No significant changes in weight, hematological parameters or clinical chemistry between the control group and the experimental groups were observed. To check for abnormalities in organs and tissues, we used microscopy to examine representative histological sections of each specified organ; the results showed no significant differences in any of the organs or tissues. Conclusion: The above findings suggest that treatment with SEH pharmacopuncture is relatively safe. Further studies on this subject are needed to yield more concrete evidence.
참고문헌 (28)
- Korean pharmacopuncture institute, "Pharmacopuncture therapy guidelines", pp.143~ (1999), Hansung printing
- Yook TH, "Clinical observation about the extent of improvement of low back pain patient through medi-acupuncture therapy", The Journal of Korean Oriental Medical Society, 16(1), pp.184~197 (1995)
- Joo HJ, "Researches on parmacopuncture", KIOM, 5, pp.193~210 (1995)
- Yang L, "Clinical application and study on Liuwei Dihuang pill composition", Journal of Zhejiang University of TCM, 34(5), pp.796~798 (2010)
- Korean pharmacopuncture institute, "Pharmacopuncture therapy guidelines", pp.12~159 (2000), Korean pharmacopuncture institute
- 박영철, "숙지황(Rehmannia glutinosa)의 약리작용과 독성", 대한한의학 방제학회지, 19(1), pp.145~160 (2011), 대한한의학방제학회
- 김승현, "승마, 우슬, 인진호, 목단피 및 빈랑자의 독성연구를 위한 안정성 시험", 생약학회지, 39(3), pp.241~245 (2008), 한국생약학회
- Chung SR, "Toxicity and lectins constituents from the seed of Cornus officinalis", Kor J Pharmacogn, 24(2), pp.177~182 (1993)
- 석지현, "택사(Alismatis Rhizoma) 추출물의 급성 경구투여 독성 연구", 한방안이비인후피부과학회지, 26(4), pp.15~25 (2013), 대한한방안이비인후피부과학회
- 전원경, "六味地黃湯의 마우스에 대한 급성독성", 대한한의학 방제학회지, 17(2), pp.65~72 (2009), 대한한의학방제학회
- Run Qiu Chen, "Construction of a traditional Chinese medicine syndrome-specific outcome measure: the Kidney Deficiency Syndrome questionnaire (KDSQ)", BMC Complementary and Alternative Medicine, 12(1) (2012), Springer Nature[DOI]
- Wang D, "Liuwei Dihuang pill in prevention and treatment of gerontological diseases", Chinese Journal of Gerontology, 31, pp.524~527 (2011)
- Jatinder S, "Liuwei Dihuang (LWDH), a traditional Chinese medicinal formula, protects against β-amyloid toxicity in transgenic caenorhabditis elegans", PLoS One, 7(8), pp.e43990~ (2012)
- Shin IS, "Inhibitory effect of Yukmijihwang-Tang, a traditional herbal formula against testosterone-induced benign prostatic hyperplasia in rats", BMC Complement Altern Med, 12(1), pp.48~ (2012)
- Chen H, "Effect of Shen-Qi-Di-Huang decoction on reducing proteinuria by preserving nephrin in adriamycin-induced nephropathy rats", Afr J Tradit Complement Altern Med, 8(4), pp.467~476 (2011)
- Perry B, "Liuwei dihuang lowers body weight and improves insulin and leptin sensitivity in obese rats", Evid Based Complement Alternat Med, 2012 (2012)[DOI]
- 김성경, "Korean Herbal Medicine for Treating Henoch-Schonlein Purpura with Yin Deficiency: Five Case Reports", Journal of Pharmacopuncture, 17(4), pp.70~75 (2014), 대한약침학회[DOI]
- 이세나, "Effects of Yukmigeehwang-hwan Pharmacopuncture Extracts on the Collagenase Activity and Procollagen Synthesis in HS68 Human Fibroblasts and Tyrosinase Activity", Korean Journal of Acupuncture, 28(1), pp.39~46 (2011), 경락경혈학회
- 최원주, "六味地黃湯加味方 약침이 연골세포에 미치는 영향", 대한한방소아과학회지, 24(1), pp.117~125 (2010), 대한한방소아과학회
- 서동민, "초기 강직성 척추염 약침치료 1례에 관한 기능적 평가와 유용성에 관한 연구", 대한침구의학회지, 19(6), pp.234~246 (2002), 대한침구의학회
- 김건호, "흰쥐의 adjuvant-induced knee arthritis에 대한 신음허 약침의 치료효과", 동의생리병리학회지, 18(4), pp.1001~1006 (2004), 한의병리학회
- Chang TY, "Effects of Achyranthis Radix aqua-acupuncture on adjuvant arthritis in rats", J Korean Oriental Med, 21(3), pp.77~87 (2000)
- 김광성, "陰谷(KI10) 산수유 약침이 난소적출 생쥐의 골다공증에 미치는 영향", Korean Journal of Acupuncture, 27(1), pp.63~85 (2010), 경락경혈학회
- 한제근, "음곡에 시술한 택사 약침이 LPS로 유도된 흰쥐의 신장염에 미치는 영향", 대한침구의학회지, 31(1), pp.51~60 (2014), 대한침구의학회
- 조시용, "車前子藥鍼이 急性腎不全 白鼠에 미치는 影響", Korean Journal of Acupuncture, 22(4), pp.117~127 (2005), 경락경혈학회
- Kim YK, "The principle and test method. toxicology", pp.15~18 (1994), Donghwagisul
- Kim YG, "Toxicology", pp.15~18 (1984), Donghwagisul
- Korea Food & Drug Administration, "Korea food & drug administration notification", pp.60~ (2005), Korea Food & Drug Administration